Volume 82, Issue 7 | Drugs

Home
Drugs
Volumes and issues
Volume 82, Issue 7

Drugs

Publishing model:: Hybrid

Submit your manuscript

Search all Drugs articles

Volume 82, Issue 7

May 2022

10 articles in this issue

PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer
Ronan Flippot
Anna Patrikidou
Karim Fizazi
Review Article 05 May 2022 Pages: 719 - 733
Lupus Nephritis: Improving Treatment Options
Myrto Kostopoulou
Sofia Pitsigavdaki
George Bertsias
Review Article 29 April 2022 Pages: 735 - 748
New Drug Delivery Systems Developed for Brain Targeting
Shruti U. Rawal
Bhoomika M. Patel
Mayur M. Patel
Review Article 21 May 2022 Pages: 749 - 792
Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews
Salmaan Kanji
Sydney Morin
Brian Hutton
Systematic Review 13 April 2022 Pages: 793 - 809
Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC
Yahiya Y. Syed
Adis Drug Evaluation 19 May 2022 Pages: 811 - 816
Part of 1 collection:

Topical Collection on Lung Cancer
Sutimlimab: First Approval
Sohita Dhillon
AdisInsight Report 12 April 2022 Pages: 817 - 823
Part of 1 collection:

AdisInsight Reports
Faricimab: First Approval
Matt Shirley
AdisInsight Report 26 April 2022 Pages: 825 - 830
Part of 1 collection:

AdisInsight Reports
Pacritinib: First Approval
Yvette N. Lamb
AdisInsight Report 14 May 2022 Pages: 831 - 838
Part of 1 collection:

AdisInsight Reports
Correction to: Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals
Fabrizio Schifano
Valeria Catalani
Amira Guirguis
Correction 27 April 2022 Pages: 839 - 839
Correction to: Daridorexant: First Approval
Anthony Markham
Correction Open access 27 April 2022 Pages: 841 - 841